Invention Grant
- Patent Title: Tricyclic compounds as anticancer agents
-
Application No.: US15573141Application Date: 2016-05-11
-
Publication No.: US10683290B2Publication Date: 2020-06-16
- Inventor: Claude A. Quesnelle , Lalgudi S. Harikrishnan , Matthew D. Hill
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Elliott Korsen
- International Application: PCT/US2016/031701 WO 20160511
- International Announcement: WO2016/183114 WO 20161117
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61P35/02
Abstract:
The present invention is directed to tricyclic compounds, pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions in the treatment of various disorders.
Public/Granted literature
- US20180127413A1 TRICYCLIC COMPOUNDS AS ANTICANCER AGENTS Public/Granted day:2018-05-10
Information query
